NSC 626992;Glycine,N-(4-chlorophenyl)-N-(phenylsulfonyl)-; 

MP 1177;2-Oxa-5,8,11,14-tetraazahexadecan-16-oic acid, 8,11-bis(carboxymethyl)-14-[2-[(2-methoxyethyl)amino]-2-oxoethyl]-6-oxo-,gadolinium complex;Gadolinium,[8,11-bis[(carboxy-kO)methyl]-14-[2-[(2-methoxyethyl)amino]-2-(oxo-kO)ethyl]-6-(oxo-kO)-2-oxa-5,8,11,14-tetraazahexadecan-16-oato(3-)-kN8,kN11,kN14,kO16]- (9CI);Gadoversetamide; Gadolinium,[8,11-bis(carboxymethyl)-14-[2-[(2-methoxyethyl)amino]-2-oxoethyl]-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oato(3-)]-; [N,N-Bis[2-[[(Carboxymethyl)[(2-methoxyethyl)carbamoyl]methyl]amino]ethyl]glycinato(3-)]gadolinium;Gadolinium,[6,9-bis[(carboxy-kO)methyl]-3-[2-[(2-methoxyethyl)amino]-2-(oxo-kO)ethyl]-11-(oxo-kO)-15-oxa-3,6,9,12-tetraazahexadecanoato(3-)-kN3,kN6,kN9,kO1]-; Gd-DTP-BMEA; OptiMARK;